Matches in Wikidata for { <http://www.wikidata.org/entity/Q64646106> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q64646106 description "assaig clínic" @default.
- Q64646106 description "clinical trial" @default.
- Q64646106 description "clinical trial" @default.
- Q64646106 description "clinical trial" @default.
- Q64646106 description "clinical trial" @default.
- Q64646106 description "ensaio clínico" @default.
- Q64646106 description "ensayo clínico" @default.
- Q64646106 description "ensayu clínicu" @default.
- Q64646106 description "essai clinique" @default.
- Q64646106 description "klinisch onderzoek" @default.
- Q64646106 description "клінічне випробування" @default.
- Q64646106 name "A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of" @default.
- Q64646106 type Item @default.
- Q64646106 label "A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of" @default.
- Q64646106 prefLabel "A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of" @default.
- Q64646106 P1132 Q64646106-DB08B605-CF74-4C9C-99BD-0AC2DC4899C5 @default.
- Q64646106 P1476 Q64646106-07C89129-4C67-408C-87BD-E752A9E1BE96 @default.
- Q64646106 P17 Q64646106-C430C91C-DF69-411A-BA64-65447D0DC2D3 @default.
- Q64646106 P17 Q64646106-E6529DC0-B87C-4A3B-809A-318259172CF4 @default.
- Q64646106 P17 Q64646106-F4FB3054-EFA9-404C-8E44-C1715E1080A6 @default.
- Q64646106 P2899 Q64646106-D2E33580-ED20-4666-A0E3-618899F6CD46 @default.
- Q64646106 P3098 Q64646106-10925E73-F1F1-44BD-889C-AE47FD5D3265 @default.
- Q64646106 P31 Q64646106-D28BDFF7-A43B-44FD-ACB0-8263C44CF236 @default.
- Q64646106 P4135 Q64646106-CD0A4F81-A07E-4E34-91C5-46576393E7E1 @default.
- Q64646106 P4844 Q64646106-2B4F28B4-5E85-456D-ADDE-F406291A1569 @default.
- Q64646106 P580 Q64646106-18921D5C-0F01-4A10-BB52-F8B397C40F39 @default.
- Q64646106 P582 Q64646106-E01EEBA8-7AD4-4C99-8640-1DF82DE6C688 @default.
- Q64646106 P8363 Q64646106-6C789B08-41B5-4453-B55D-5DEECCBF1A70 @default.
- Q64646106 P1132 "+885" @default.
- Q64646106 P1476 "A Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) and Both Active Treatments to Topical Gel Placebo (Actavis Mid-Atlantic Llc) in the Treatment of Mild to Severe Acne Vulgaris" @default.
- Q64646106 P17 Q242 @default.
- Q64646106 P17 Q30 @default.
- Q64646106 P17 Q668 @default.
- Q64646106 P2899 "+12" @default.
- Q64646106 P3098 "NCT01501799" @default.
- Q64646106 P31 Q30612 @default.
- Q64646106 P4135 "+40" @default.
- Q64646106 P4844 Q352348 @default.
- Q64646106 P580 "2011-07-01T00:00:00Z" @default.
- Q64646106 P582 "2011-12-01T00:00:00Z" @default.
- Q64646106 P8363 Q78089383 @default.